Navigation Links
Angiotech to Establish Separate Operating and Royalty Businesses
Date:7/7/2008

ies a total equity

value for API of $625 million, assuming $75 million in cash and cash

equivalents at API at closing and no debt, other than the guarantees

of the remaining amounts of Angiotech's two existing debt issues. The

proposed transaction at this value enables Angiotech to raise a

significant amount of capital to address the Company's current

capital structure issues with more limited dilution than would likely

be possible if Angiotech were to attempt to raise similar amounts of

capital using security structures available to Angiotech on a

consolidated basis.

- Flexible transaction size to optimize use of capital. Angiotech

expects to raise a minimum of US$200 million in gross proceeds

through this transaction. Depending upon the interest level in the

contemplated tender offers for Angiotech's two outstanding debt

issues, the Company may elect to raise up to US$300 million. This

transaction structure allows Angiotech the flexibility to elect to

raise a variable amount of capital, at the Company's option,

depending on the expected cost of retiring selected amounts of each

outstanding debt issue.

- Align capitalization with business risk, strategy and structures. By

forming and capitalizing API, Angiotech has established a plan to

achieve a more equity oriented capital structure for its operating

businesses, more consistent with its original strategy and with peer

companies in the life sciences industry. With the opportunity to

pursue an initial public offering of API in the future, or other

financial and strategic alternatives together with Ares and New Leaf,

API will have improved financial flexibility, enabling API to better

capitalize on its various business and product development


'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Earlier this year in a June 24 ... the Adult Stem Cell Technology Center, LLC ( ASCTC ... appreciated unique property of adult tissue stem cells. ... in the Past, Important for the Future,” embodied the ... gave the address at the 4th World Congress on ...
(Date:12/24/2014)... December 23, 2014 The ... such as its definition, classification, application and ... specification, manufacturing process, and product cost structure. ... applications. The analysis also covers upstream raw ... industry development trend and proposals. In the ...
(Date:12/24/2014)... Dec. 23, 2014 China Biologic Products, ... a leading fully integrated plasma-based biopharmaceutical company in ... its majority-owned subsidiary, Shandong Taibang Biological Products Co. ... from the China Food and Drug Administration (the ... As previously disclosed in the Company,s public filings, ...
(Date:12/24/2014)...  Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... Trial Application (CTA) with the United Kingdom,s ... regulatory approval to initiate clinical trials for the continued ... Contingent on the Company receiving CTA regulatory approval, the ... assess the safety, tolerability and dose escalation of Anatabine ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... profound implications for nanoelectronic components. Researchers from the Nano-Science ... in collaboration with Japanese researchers, have shown how electrons ... between their motion and their attached magnetic field ... unprecedented control over the spin of electrons and may ...
... 21, 2011 Leading organizations understand the value of ... operational tactics across numerous functions. As pharmaceutical, biotechnology and ... must also evolve and develop new capabilities while refining ... " The Future of Market Research: Challenges ...
... Electronics researchers love graphene. A two-dimensional sheet of carbon ... electrons, which rocket through the material with 100 times ... devices will be challenging, say researchers at the National ... show that layering graphene on a substrate transforms its ...
Cached Biology Technology:Curved carbon for electronics of the future 2Role of Market Research Evolving to Take on a More Strategic Responsibility 2Real-world graphene devices may have a bumpy ride 2
(Date:12/19/2014)... 2014 Research and Markets ( ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... in July 2012, Apple introduced the fingerprint reading ... the only device of Apple incorporating such a ...
(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... The discrimination that obese people feel, whether it is ... in the workplace, may have a direct impact on ... University. "Obesity is a physiological issue, but when ... sense of being discriminated againstit can make matters worse ...
... study of 45-million-year-old pollen from Pine Island west of Fort ... geologic history, showing Florida could be 10 million to 15 ... land in Florida during the early Eocene opens the possibility ... that time, including their adaptation, evolution and dispersal until the ...
... Indiana Jones as they search for plants in remote ... of life-saving new medicines, are currently trying to figure ... affect their work. That,s the topic of an article ... C&EN Associate Editor Carmen Drahl explains that ...
Cached Biology News:Stigma weighs heavily on obese people, contributing to greater health problems 2UF Pine lsland pollen study leads to revision of state's ancient geography 2UF Pine lsland pollen study leads to revision of state's ancient geography 3
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
... Kit is a 2-color staining method for ... to detect apoptotic cells by flow cytometry. ... required for measuring apoptosis in cells, including ... reagent performance; washing, reaction and rinsing buffers ...
The sample holders for gels are used to hold gels in place in the multi-sample tray I, which is used with Molecular Imager FX imaging systems....
... The ApopTag Fluorescein In Situ ... in situ by the indirect TUNEL ... is conjugated to a Fluorescein reporter ... for 40 samples. Results are analyzed ...
Biology Products: